Volume 71, Issue 1, January 2013

ISSN: 0344-5704 (Print) 1432-0843 (Online)

In this issue (30 articles)

previous Page of 2

  1. No Access

    Review Article

    Assessing the in vivo efficacy of biologic antiangiogenic therapies

    Peter M. Wilson, Melissa J. LaBonte… Pages 1-12
    Look Inside Get Access

  2. No Access

    Review Article

    Therapeutic potential of targeting ceramide/glucosylceramide pathway in cancer

    Melis Kartal Yandım, Elif Apohan, Yusuf Baran Pages 13-20
    Look Inside Get Access

  3. No Access

    Original Article

    A phase I study of tasisulam sodium (LY573636 sodium), a novel anticancer compound, administered as a 24-h continuous infusion in patients with advanced solid tumors

    Michael S. Gordon, Robert Ilaria Jr.… Pages 21-27
    Look Inside Get Access

  4. No Access

    Original Article

    Phase I study of bevacizumab combined with irinotecan and S-1 as second-line chemotherapy in patients with advanced colorectal cancer

    Hitoshi Kusaba, Taito Esaki, Junji Kishimoto… Pages 29-34
    Look Inside Get Access

  5. Original Article

    Pharmacokinetic study of omacetaxine mepesuccinate administered subcutaneously to patients with advanced solid and hematologic tumors

    John Nemunaitis, Alain Mita, Joe Stephenson… Pages 35-41
    Download PDF (264KB) View Article

  6. No Access

    Original Article

    Two-year adjuvant imatinib mesylate after complete resection of localized, high-risk GIST with KIT exon 11 mutation

    Yoon-Koo Kang, Byung Woog Kang, Seock-Ah Im… Pages 43-51
    Look Inside Get Access

  7. No Access

    Original Article

    Phase I study of lonafarnib (SCH66336) in combination with trastuzumab plus paclitaxel in Her2/neu overexpressing breast cancer: EORTC study 16023

    Bojana Milojkovic Kerklaan, Veronique Diéras… Pages 53-62
    Look Inside Get Access

  8. No Access

    Original Article

    Phase I trial of exemestane in combination with metformin and rosiglitazone in nondiabetic obese postmenopausal women with hormone receptor–positive metastatic breast cancer

    Francisco J. Esteva, Stacy L. Moulder… Pages 63-72
    Look Inside Get Access

  9. No Access

    Original Article

    Formation of active products of benzaldehyde dimethane sulfonate (NSC 281612, DMS612) in human blood and plasma and their activity against renal cell carcinoma lines

    Robert A. Parise, Bean N. Anyang, Julie L. Eiseman… Pages 73-83
    Look Inside Get Access

  10. No Access

    Original Article

    Uridine diphosphate glucuronosyl transferase 1 family polypeptide A1 gene (UGT1A1) polymorphisms are associated with toxicity and efficacy in irinotecan monotherapy for refractory pancreatic cancer

    Naminatsu Takahara, Yousuke Nakai, Hiroyuki Isayama… Pages 85-92
    Look Inside Get Access

  11. Original Article

    A Phase I study of pazopanib in combination with gemcitabine in patients with advanced solid tumors

    Ruth Plummer, Ayman Madi, Melinda Jeffels… Pages 93-101
    Download PDF (266KB) View Article

  12. No Access

    Original Article

    Vinorelbine and capecitabine in anthracycline- and/or taxane-pretreated metastatic breast cancer: sequential or combinational?

    Jian Zhang, Shi-Yang Gu, Yu Gan, Zhong-Hua Wang… Pages 103-113
    Look Inside Get Access

  13. No Access

    Original Article

    Phase I study of 5-aza-2′-deoxycytidine in combination with valproic acid in non-small-cell lung cancer

    B. F. Chu, M. J. Karpenko, Z. Liu, J. Aimiuwu… Pages 115-121
    Look Inside Get Access

  14. No Access

    Original Article

    Evaluation of the pharmacokinetics and safety of bosutinib in patients with chronic hepatic impairment and matched healthy subjects

    Richat Abbas, Stephan Chalon, Cathie Leister… Pages 123-132
    Look Inside Get Access

  15. No Access

    Original Article

    PK-PD modeling of combination efficacy effect from administration of the MEK inhibitor GDC-0973 and PI3K inhibitor GDC-0941 in A2058 xenografts

    Edna F. Choo, Chee M. Ng, Leanne Berry… Pages 133-143
    Look Inside Get Access

  16. No Access

    Original Article

    Combination of low-dose docetaxel and standard-dose S-1 for the treatment of advanced gastric cancer: efficacy, toxicity, and potential predictive factor

    Yuehong Cui, Qian Li, Yiyi Yu, Yong Chen, Yi Feng… Pages 145-152
    Look Inside Get Access

  17. No Access

    Original Article

    Changing the expression vector of multidrug resistance genes is related to neoadjuvant chemotherapy response

    Nicolay V. Litviakov, Nadezhda V. Cherdyntseva… Pages 153-163
    Look Inside Get Access

  18. No Access

    Original Article

    Combination treatment of localized concurrent chemoradiation therapy and transarterial chemoembolization in locally advanced hepatocellular carcinoma with intrahepatic metastasis

    Mi Sung Park, Seung Up Kim, Jun Yong Park… Pages 165-173
    Look Inside Get Access

  19. No Access

    Original Article

    Effects of tumor type, degree of obesity, and chemotherapy regimen on chemotherapy dose intensity in obese cancer patients

    T. Miyahara, S. Mochinaga, S. Kimura, N. Aragane… Pages 175-182
    Look Inside Get Access

  20. No Access

    Original Article

    Oblimersen in combination with temozolomide and albumin-bound paclitaxel in patients with advanced melanoma: a phase I trial

    Patrick A. Ott, Jason Chang, Kathleen Madden… Pages 183-191
    Look Inside Get Access
previous Page of 2